Head-to-head · WeighScore
Always Wellness and Recovery vs NexLife
The verdict
NexLife takes it — 68.5/100 to 57.5/100.
NexLife grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NexLife is a LegitScript-certified telehealth platform offering compounded semaglutide (from $145/mo) and compounded tirzepatide (from $186/mo).
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Always Wellness and Recovery | NexLife |
|---|---|---|
| WeighScore | 57.5/100 | 68.5/100 |
| Grade | C | C |
| Scorecard rank | #396 | #147 |
| Semaglutide | Not disclosed | $165/mo (compounded) |
| Tirzepatide | Not disclosed | $215/mo (compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #396 · C
Strengths
- Compounded semaglutide and tirzepatide with personalized dosing, not one-size-fits-all
- No mandatory subscription — cancel anytime
- Every case reviewed by a board-certified US physician (medical director Dr. M. Reyes, MD)
- Unlimited HIPAA-secure messaging with the care team
- Lab work included where clinically indicated; free discreet shipping in 3-5 days
Where it loses points
- Pricing is not shown until you complete an application
- Compounded GLP-1s are not FDA-approved finished products
- No LegitScript certification visible and the compounding pharmacy is not named
- Cash-pay only — no insurance billing
Graded #147 · C
Strengths
- LegitScript certified platform
- Works exclusively with LegitScript-certified, NABP-accredited pharmacies — strongest pharmacy trust signal in the dataset
- Both semaglutide and tirzepatide at competitive pricing
- Semaglutide from $145/mo on the 12-month plan ($165/mo month-to-month) - among the lowest in the dataset
Where it loses points
- State availability not publicly disclosed
- Compounded only — no brand-name options
- Also covers hormone optimization and longevity
- Lowest advertised rates ($145 sema / $186 tirz) require a 12-month plan commitment
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.